Matthew W. Strobeck - Director at Accelerate Diagnostics, Inc

Issuer-level insider activity

Role
Director
Issuer ticker
AXDX
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Matthew W. Strobeck since 19 Jul 2025

Reported holdings for Matthew W. Strobeck in Accelerate Diagnostics, Inc

Form 4 holding Director

Accelerate Diagnostics, Inc

Security class
Employee Restricted Stock Units
Shares / value
236,842
Estimated value
$1,039,736
Report date
28 Jun 2023
Price
$4.39
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Accelerate Diagnostics, Inc

Security class
Common Stock
Shares / value
120,682
Estimated value
$529,794
Report date
23 Jan 2024
Price
$4.39
Ownership
By Birchview Fund, LLC
Form 4 holding Director

Accelerate Diagnostics, Inc

Security class
Common Stock
Shares / value
2,000
Estimated value
$8,780
Report date
23 Jan 2024
Price
$4.39
Ownership
As UGMA Custodian for minor children
Form 4 holding Director

Accelerate Diagnostics, Inc

Security class
Common Stock Warrants (right to buy)
Shares / value
100,000
Estimated value
Report date
23 Jan 2024
Price
Ownership
By Birchview Fund, LLC
Underlying class
Common Stock
Underlying amount

Transaction history for Matthew W. Strobeck in Accelerate Diagnostics, Inc

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .